StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Potassium Carbonate → tert-Butyl (5-{[4-[(4-morpholin-4-ylphenyl)amino]-1,1-dioxido-3-oxo-5-phenylisothiazol-2(3H)-yl]methyl}pyridin-2-yl)carbamate

HRID 729267
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 729267
[N:1]1([C:7]2[CH:12]=[CH:11][C:10]([NH2:13])=[CH:9][CH:8]=2)[CH2:6][CH2:5]N[CH2:3][CH2:2]1.Cl[C:15]1[C:16](=[O:28])[NH:17][S:18](=[O:27])(=[O:26])[C:19]=1[C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1.[C:29]([O:33][C:34](=[O:44])[NH:35][C:36]1[CH:41]=[CH:40][C:39]([CH2:42]Br)=[CH:38][N:37]=1)([CH3:32])([CH3:31])[CH3:30].C(=O)([O-])[O-:46].[K+].[K+]>CN(C=O)C>[N:1]1([C:7]2[CH:8]=[CH:9][C:10]([NH:13][C:15]3[C:16](=[O:28])[N:17]([CH2:42][C:39]4[CH:40]=[CH:41][C:36]([NH:35][C:34](=[O:44])[O:33][C:29]([CH3:32])([CH3:31])[CH3:30])=[N:37][CH:38]=4)[S:18](=[O:27])(=[O:26])[C:19]=3[C:20]3[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=3)=[CH:11][CH:12]=2)[CH2:2][CH2:3][O:46][CH2:5][CH2:6]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 4

HCID 11430Potassium CarbonateHCID 4229251-(4-Aminophenyl)piperazineHCID 23030321tert-Butyl (5-(bromomethyl)pyridin-2-yl)carbamateHCID 686616564-Chloro-5-phenylisothiazol-3(2H)-one 1,1-dioxide

Produkt 1

HCID 86623727tert-Butyl (5-{[4-[(4-morpholin-4-ylphenyl)amino]-1,1-dioxido-3-oxo-5-phenylisothiazol-2(3H)-yl]methyl}pyridin-2-yl)carbamate
Ausbeute 16,2 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

(4-piperazin-1-ylphenyl)amine (0.42 g, 2.3 mmol) was added to an ice cold solution of 4-chloro-5-phenylisothiazol-3(2H)-one 1,1-dioxide (0.57 g, 2.3 mmol) in DMF (4 ml) and the mixture was stirred for 1 h. tert-Butyl[5-(bromomethyl)pyridin-2-yl]carbamate (0.67 g, 2.3 mmol) and anhydrous potassium carbonate (0.32 g, 2.3 mmol) were added. The reaction mixture was stirred over night, concentrated and the residue was dissolved in DCM. The mixture was washed with water and concentrated and the residue was purified using preparative HPLC to give the title compound (0.22 g, 16%). 1H NMR (400 MHz, d6-DMSO): δ 1.42 (s, 9H), 3.10-3.11 (m, 4H), 3.57-3.66 (m, 1H), 3.71-3.74 (m, 4H), 3.78-3.84 (m, 1H), 5.70 (s, 1H), 6.95-6.98 (m, 1H), 7.20-7.25 (m, 1H), 7.38-7.42 (m, 5H), 7.48-7.51 (m, 1H), 7.70-7.73 (m, 2H), 7.78 (s, 1H), 9.51 (s, 1H).

Aufarbeitung

  1. additionwere added
  2. concentrationconcentrated
  3. dissolutionthe residue was dissolved in DCM
  4. washThe mixture was washed with water
  5. concentrationconcentrated
  6. customthe residue was purified

Quellen und Nachweise

ORD-Eintrag
ord-ea343d30362c4892a7f2c7856a6a9000
Quelldatensatz
uspto-grants-2009_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07582629B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion